Diverse Evolutionary Histories for β-adrenoreceptor Genes in Humans  by Cagliani, Rachele et al.
ARTICLE
Diverse Evolutionary Histories
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In humans, three genes—ADRB1, ADRB2 and ADRB3—encode b-adrenoreceptors (ADRB); these molecules mediate the action of cate-
cholamines in multiple tissues and play pivotal roles in cardiovascular, respiratory, metabolic, and immunological functions. Genetic
variants in ADRB genes have been associated with widespread diseases and conditions, but inconsistent results have often been
obtained. Here, we addressed the recent evolutionary history of ADRB genes in human populations. Although ADRB1 is neutrally
evolving, most tests rejected neutral evolution for ADRB2 in European, African, and Asian population samples. Analysis of inferred
haplotypes for ADRB2 revealed three major clades with a coalescence time of 1–1.5 million years, suggesting that the gene is either sub-
jected to balancing selection or undergoing a selective sweep. Haplotype analysis also revealed ethnicity-speciﬁc differences. Addition-
ally, we observed signiﬁcant deviations from Hardy-Weinberg equilibrium (HWE) for ADRB2 genotypes in distinct European cohorts;
HWE deviation depends on sex (only females are in disequilibrium), and genotypes displaying maximum and minimum relative ﬁtness
differ across population samples, suggesting a complex situation possibly involving epistasis or maternal selection. Overall, our data
indicate that future association studies involving ADRB2will beneﬁt from taking into account ethnicity-speciﬁc haplotype distributions
and sex-based effects. With respect to ADRB3, our data indicate that the gene has been subjected to a selective sweep in African popu-
lations, the Trp64 variant possibly representing the selection target. Given the previous association of the ancestral ADRB3 Arg64 allele
with obesity and type 2 diabetes, dietary adaptations might represent the underlying selective force.Introduction
Adrenergic receptors are G protein-coupled molecules that
mediate the action of catecholamines in multiple tissues.
In particular, they are an integral part of the sympathetic
nervous system and play pivotal roles in cardiovascular,
respiratory, metabolic, and immunological functions.
Adrenergic receptors have been subdivided into two
major types, a and b, on the basis of agonist-mediated
responses, with subsequent classiﬁcation into subtypes
based on differential tissue localization (reviewed in 1). As
far as members of the b type (ADRB) are concerned, three
distinct receptors have been identiﬁed in humans: b1, b2
and b3, all encoded by small intronless or single-intron
genes located on chromosomes 10, 5 and 8, respectively.
ADRBs have been the subjects of intensive investigations
as a result of their possible role in the pathophysiology of
widespread conditions such as insulin resistance, obesity
(MIM 601665), asthma (MIM 600807), and cardiovascular
disorders.2–6 Also, ADRBs are targets of many commonly
used drugs; thus, the identiﬁcation and analysis of func-
tional variants is extremely relevant to pharamacogenetic
studies. As a consequence, commonly occurring polymor-
phisms have been searched for and studied in ADRB
genes and particular focus has been placed on nonsynon-
ymous SNPs. A common R389G variant in ADRB1 (MIM
109630) has been shown7 to inﬂuence the receptor’s64 The American Journal of Human Genetics 85, 64–75, July 10, 200coupling properties; the association of this SNP with
obesity is controversial,8,9 but experiments in transgenic
mice have indicated that the R389 allele predisposes to
heart failure.10 Of four relatively common nonsynony-
mous SNPs in ADRB2 (MIM 109690), three are functional
in vitro: Gly16 leads to enhanced agonist-mediated down-
regulation,11 Glu27 reduces such regulation,11 and Ile64
shows12 impaired agonist binding and decreased adenyl
cyclase activity. Moreover, additional functional variants
have been identiﬁed in the promoter region of ADRB2.13
The phenotypic effect of coding SNPs has been investi-
gated in many studies; associations of Gly16 and Glu27
with asthma and obesity, respectively, have been reported,
although not always validated in independent studies
(reviewed in 14). Similarly, contradictory results have been
obtained among studies aiming at correlating genetic
variants in ADRB2 with hypertension (reviewed in 15). In
addition, conditions such as autism (MIM 209850),16,17
preterm delivery,18–21 cerebral palsy,22 parasitic infec-
tion,23 rheumatoid arthritis (MIM 180300),24,25 and tem-
poromandibular joint disorder26 have been associated
with ADRB2 polymorphisms. With respect to ADRB3
(MIM 109691), a low-frequency ancestral allele has been
associated with obesity and type 2 diabetes (MIM
125853) in some but not all populations (reviewed in 27).
Therefore, in analogy to many other cases, studies aim-
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have often been inconsistent with one another; in general,
the lack of consistency among association studies is
thought to be due to both false-positive and false-negative
results rather than to variability in association for popula-
tions with different ethnic origins.28 Whatever the reason,
a clear picture of whether ADRB variants inﬂuence disease
susceptibility is still missing.
Further insight into the genetic basis of common
diseases can be obtained through molecular evolutionary
studies of candidate loci; indeed, inference about selection
models operating on speciﬁc gene regions implicitly
implies the presence of functional variantswith some effect
on ﬁtness (at some time in human history). Moreover, it
has recently been proposed (reviewed in 29,30) that the shift
of environment and lifestyle that has been associated with
two extremely relevant transitions, the out-of-Africa
migration and the development of agricultural methods,
might have rendered maladaptive genetic variants that
had been selected for in earlier stages of human history.
This hypothesis has been explicitly formulated for a few
commondiseases, suchasobesity,hypertension,andasthma.
On these bases, we set out to verify whether the neutral
model of evolution applies to ADRB genes in humans.
Material and Methods
DNA Samples, Sequencing, and Genotyping
Human genomic DNA for East Asians (EAS), Australian Aborigines
(AUA), andnative SouthAmericans (NSA)was obtained fromeither
the Coriell Institute for Medical Research or the European Collec-
tion of Cell Cultures. For population genetics analyses, the 6 kb
genomic portion encompassing ADRB2 coding and promoter
regionswas PCR ampliﬁed in overlapping fragments. PCR products
were treated with ExoSAP-IT (USB Corporation, Cleveland, OH,
USA), directly sequenced on both strands with a Big Dye Termi-
nator Sequencing Kit (v3.1 Applied Biosystems), and run on an
Applied BiosystemsABI 3130XLGenetic Analyzer (Applied Biosys-
tems). Sequences were assembled with AutoAssembler version
1.4.0 (Applied Biosystems) and inspectedmanually by two distinct
operators, and singletons were reampliﬁed and resequenced.
Primer sequences are available upon request. The number of
subjects resequenced was as follows: AUA, 12; NSA, 24; EAS, 25.
For the study of haplotype and genotype frequencies in an
Italian population sample, rs1042714 (Arg16Gly) and rs1042713
(Gln27Glu) were genotyped in 654 Italian individuals. Genomic
DNA from these subjects was obtained from different sources; in
particular, 263 subjects were collected and genotyped as previ-
ously described,31 and the remaining individuals were either
provided by the Telethon Bank of DNA, Nerve and Muscle Tissues
(no. GTF02008), located at the Department of Neurological
Sciences, IRCCS Ospedale Maggiore Policlinico, Mangiagalli and
Regina Elena Foundation, Milan, or recruited as volunteers at
the Scientiﬁc Institute IRCCS E.Medea, after informed consent
was obtained. Genotyping for these subjects was performed by
direct sequencing of the gene region encompassing rs1042714
and rs1042713, with the use of the same procedures described
above. The study was approved by the Ethical Committee of the
Scientiﬁc Institute IRCCS E. Medea-Associazione La Nostra Fami-
glia, in agreement with Italian standards.ThData Retrieval and Haplotype Construction
Genotype data for two population samples, one of African and one
of European ancestry, were retrieved from the SeattleSNPs website.
In particular, ADRB2 and ADRB3 have been resequenced in
24 Yoruba (YRI) and 24 Utah residents with ancestry from
northern and western Europe. Data for ADRB1 refer to 24 African
Americans (AA) and 23 individuals with European ancestry
(20 Utah residents with ancestry from northern and western
Europe and three French individuals). Populations with European
ancestry are hereafter referred to as EU. The nucleotide positions
for all analyzed genes correspond to those of SeattleSNPs, which
in turn derive from the following GenBank accession numbers:
ADRB1, AY567837; ADRB2, DQ094845; ADRB3, DQ104441.
Genotype data for 238 resequenced human genes were derived
from the National Institute of Environmental Health Sciences
(NIEHS) SNPs Program website. In particular, we selected genes
that had been resequenced in genotype samples of populations
of deﬁned ethnicity, including AA, EU, YRI, and EAS (NIEHS panel
2). Data from the AA and EU samples were used as a comparison
for ADRB1, which has been resequenced in these same popula-
tions. Similarly, for ADRB2 and ADRB3, the comparison was per-
formed with YRI and EU samples.
Haplotypeswere inferredwith PHASE version 2.1,32,33 a program
for reconstructing haplotypes from unrelated genotype data
through a Bayesian statistical method. Inferred haplotypes for all
individuals used in this study are available in the Supplemental
Data (Tables S1 and S2, available online).
Statistical Analysis
Tajima’s D statistic,34 Fu and Li’s D* and F*35 statistics, as well as
diversity parameters qW
36 and p37 and Fay and Wu’s H,38 were
calculated with libsequence,39 a Cþþ class library providing an
object-oriented framework for the analysis of molecular popula-
tion-genetic data. The scaled per-nucleotide recombination para-
meter (R ¼ 4Ner) was estimated with MaxDip.40
Calibrated coalescent simulations were performed with the cosi
package41 and its best-ﬁt parameters for YRI, AA, EU, and Asian
populations with 10000 iterations.
A composite-likelihood-ratio test and coalescent simulations
under a selective sweep regime were performed with the clsw
and ssw programs, kindly provided by Yuseob Kim.
The FST statistic
42 estimates genetic differentiation among pop-
ulations and was calculated as previously proposed.43
The multilocus HKA test was performed with the HKA software
distributed by Jody Hey. Sixteen reference loci were randomly
selected among NIEHS loci that are shorter than 20 kb and have
been resequenced in genotype samples of the three populations
(YRI, EU, and EAS; panel 2). The only criterion was that Tajima’s
D did not suggest the action of natural selection (i.e., DT is higher
than the 5th and lower than the 95th percentiles in the distribution
of NIEHS genes). The reference set was accounted for by the
following genes: VNN3 (MIM 606592), PLA2G2D (MIM 605630),
MB (MIM 160000),MAD2L2 (MIM 604094), HRAS (MIM 190020),
CYP17A1 (MIM 609300), ATOX1 (MIM 602270), BNIP3 (MIM
603293), CDC20 (MIM 603618), NGB (MIM 605304), TUBA1
(MIM191110),MT3 (MIM139255),NUDT1 (MIM600312),PRDX5
(MIM606583), RETN (MIM605565), and JUND (MIM165162). For
each locus, 1000 coalescent simulations were performed with the
cosi package41 and only neutrally evolving sites were considered.
Median-joining networks for the inference of haplotype gene-
alogy were constructed with NETWORK 4.5.44 Estimate of the
time to the most recent common ancestor (TMRCA) was obtainede American Journal of Human Genetics 85, 64–75, July 10, 2009 65
Table 1. Summary Statistics for ADRB Genes
qW
d pd Tajima’s D Fu & Li’s D Fu & Li’s F
Gene La Pop. Nb Sc Value Ranke Value Ranke Value pf Value pf Value pf
ADRB1 9.4 AA 48 35 8.73 0.50 5.75 0.31 1.16 0.17 0.72 0.037 0.02 0.16
EU 46 22 5.54 0.53 7.39 0.69 1.09 0.099 1.12 0.059 1.33 0.048
ADRB2 6 YRI 48 35 13.65 0.89 17.86 0.98 1.05 0.0066 0.29 0.34 0.26 0.12
EU 46 27 10.63 0.93 19.17 0.98 2.68 0.0003 1.32 0.031 2.20 0.0012
ADRB3 7.4 YRI 48 23 7.96 0.42 3.47 0.11 1.84 0.048 1.75 0.12 2.15 0.060
EU 46 8 2.80 0.14 1.59 0.09 1.20 0.049 1.62 0.090 1.76 0.064
a Length of the analyzed region (from the most 50 resequenced nucleotide to the end of the 30 UTR).
b Sample size (chromosomes).
c Number of segregating sites.
d Nucleotide diversity indexes (3 104).
e Percentile rank relative to the distribution of 238 5 kb windows.
f p values obtained from coalescent simulations.via a phylogeny-based approach implemented in NETWORK, with
the use of amutation rate based on the number of ﬁxed differences
between human and chimpanzee and the assumption of a separa-
tion time from humans of 6 MY ago.45 A second TMRCA estimate
was derived from application of a maximum-likelihood coalescent
method implemented in GENETREE.46,47 Again, themutation rate
m was obtained on the basis of the divergence between human
and chimpanzee and under the assumption of a generation time
of 25 yrs. Using this m and q maximum likelihood (qML), we esti-
mated the effective population-size parameter (Ne). With these
assumptions, the coalescence time, scaled in 2Ne units, was con-
verted into years. For the coalescence process, 106 simulations
were performed.
All calculations were performed in the R environment.48
Results
Nucleotide Diversity and Neutrality Tests
for ADRB Genes
The three ADRB genes have been included in the Seattle
SNPs variation-discovery resource (SeattleSNPs, NHLBI
Program for Genomic Applications) and have been fully
resequenced in samples of two populations with African
(either YRI or AA) and European origin (EU).
We exploited the availability of these data to calculate
nucleotide-diversity parameters for the three genes in these
population samples; in particular, all the analyses reported
below have been performed on gene regions extending
from themost 50 resequenced nucleotide to the 30 UTR end.
Nucleotide diversity was assessed through two indexes:
qW,
36 an estimate of the expected per-site heterozigosity,
and p,37 the average number of pairwise sequence nucleo-
tide differences. Under neutral evolution, values of qWand
p are roughly equal. The Tajima’s D statistic (DT,
34) is
commonly used to evaluate their difference and, therefore,
departure from neutrality. Positive values of DT indicate an
excess of intermediate-frequency variants and are evidence
of balancing selection, and negative DT values indicate
either purifying selection or a high representation of rare66 The American Journal of Human Genetics 85, 64–75, July 10, 200variants as a result of a selective sweep. Fu and Li’s F and
D (as well as F* and D*35) statistics are also based on SNP
frequency spectra and differ from Tajima’s D in that they
also take into account whethermutations occur in external
or internal branches of a genealogy. Because population
history, in addition to selective processes, is known to
affect frequency spectra and, therefore, all related statistics,
we performed coalescent simulations by using a population
genetics model that incorporates demographic scenarios.41
Moreover, to the same aim, we exploited the conundrum
whereby selection acts on a single locus while demography
affects the whole genome, calculating diversity parameters
and test statistics for a set of 238 genes resequenced by
the NIEHS program; in particular, a 5 kb window was ran-
domly selected for each gene (see Material and Methods).
Data for ADRB genes are reported in Table 1 and indicate
that no departure from neutrality is observed for ADRB1.
Conversely, signiﬁcantly positive values of DT and Fu and
Li’s D and F were obtained for ADRB2 in Europeans. In Afri-
cans, the presence of nine singletons in ADRB2 yielded low
values for Fu and Li’s statistics but DT ranked highly when
compared to the distribution of 238 resequenced genes in
African populations (Table 2). Moreover, both qW and p
results were higher for ADRB2 than for most NIEHS genes
(Table 1).
Finally, analysis of ADRB3 revealed negative statistics
(with marginally signiﬁcant p values), as well as low levels
of nucleotide variation, in YRI and EU (Table 1).
These ﬁndings prompted us to further investigate the
evolutionary history of ADRB2 and ADRB3.
The Signature of Selection at ADRB2
As a ﬁrst step, we wished to verify whether rejection of the
neutral model was also veriﬁed for other human popula-
tion samples. We therefore resequenced the 6 kb encom-
passing ADRB2 coding and promoter regions in three
additional populations: EAS, NSA, and AUA. Whenmodel-
ﬁtting parameters were available (i.e., for EAS), we applied9
Table 2. Summary Statistics for ADRB2 in Five Human Populations
Tajima’s D Fu & Li’s D* Fu & Li’s F*
Pop. Na Sb Value pc Rankd Value pc Rankd Value pc Rankd
YRI 48 35 1.05 0.0066 0.99 0.22 0.34 0.59 0.27 0.11 0.82
EU 46 27 2.68 0.0003 0.99 0.93 0.083 0.91 1.83 0.0043 0.99
EAS 50 30 1.59 0.038 0.94 1.56 0.0052 0.99 1.87 0.0053 0.99
NSA 48 22 1.33 0.047 n.a.e 1.38 0.035 n.a.e 1.61 0.020 n.a.e
AUA 24 26 0.69 0.18 n.a.e 0.75 0.18 n.a.e 0.85 0.17 n.a.e
a Sample size (chromosomes).
b Number of segregating sites.
c p values obtained from coalescent simulations.
d Percentile rank relative to the distribution of 5 kb windows.
e Not available.a population genetics model41 for coalescent simulations;
in the case of AUA and NSA, the standard neutral model
was used. Nucleotide diversity parameters and neutrality
tests are shown in Table 2 and indicate that, in analogy
to EU, one or more statistics rejected neutrality for all pop-
ulation samples, excluding AUA. In agreement with these
data, both DT and Fu and Li’s F* and D* display a high
percentile rank in the distribution of NIEHS genes for EU
and EAS (Table 2).
Under neutral evolution, the amount of within-species
diversity is predicted to correlate with levels of between-
species divergence, because both depend on the neutral
mutation rate.49 We performed a multilocus HKA test by
using the HKA software, which allows estimation of statis-
tical signiﬁcance through coalescent simulations (see
Material and Methods). As above, the latter were per-
formed with the use of a previously described demographic
model;41 due to the lack of a demographic model, the test
was not performed for AUA and NSA. Signiﬁcant results
were obtained for EU, YRI, and EAS (Table 3), and in all
cases, the test of maximum cell value50 indicated ADRB2
as an outlier, its removal from the gene set yielding nonsig-
niﬁcant tests (Table 3).
Next, we wished to analyze the structure of ADRB2
inferred haplotypes. Construction of a median-joining
network44 (Figure 1) revealed the presence of three major
clades (haplogroups A, B, and C, hereafter referred to as
HA, HB, and HC) separated by long branch lengths, each
containing common inferred haplotypes. HC is further splitThinto two subclades (referred to as HC 1 and HC2). In order to
estimate the TMRCA of the three inferred haplotype clades,
we applied a phylogeny-based method44 based on the
measure r, the average pairwise difference between the
two haplotype clusters. The result of r was equal to 10.58,
so that, with the use of a mutation rate based on 77 ﬁxed
differences between chimpanzee and human and a separa-
tion time of 6MY,45 we estimated a TMRCAof 1.65MY (SD:
352 KY). In order to obtain a second TMRCA estimate, we
used GENETREE, which is based on amaximum-likelihood
coalescent analysis.46,47 The method assumes an inﬁnite-
site model without recombination, and, therefore, haplo-
types and sites that violate these assumptions need to be
removed. In this case, 16 single segregating sites had to be
removed. The resulting gene tree, rooted with the use of
the chimpanzee sequence, is partitioned into three major
branches (Figure S1). A maximum-likelihood q estimate
(qML) of 4 was obtained, resulting in an estimated effective
population size (Ne) of 10667, a value comparable to most
ﬁgures reported in the literature.51 With this method, the
TMRCAamounted to 1.05MY (SD: 293KY). A thirdTMRCA
estimate of 1.56 MY was obtained by applying a previously
described method52 that calculates the average sequence
divergence separating the MRCA and each of the chromo-
somes. All TMRCAs are not unusually deep; estimates for
neutrally evolving autosomal human loci range between
0.8 and 1.5 MY.51
The structure of the inferred haplotype genealogy
deserves some comments. The allelic status at amino acidTable 3. Multilocus HKA Results for ADRB2
Multilocus HKA Multilocus HKA Excluding ADRB2
Pop. Likelihooda Max Cell Valueb Likelihooda Max Cell Valueb
YRI 16.94 (0.008) 5 (<0.001) 10.66 (0.19) 1.84 (0.16)
EU 28.54 (0.008) 6.52 (0.010) 20.53 (0.07) 2.55 (0.28)
EAS 30.07 (0.019) 10.38 (<0.001) 19.05 (0.17) 3.71 (0.18)
a Sum of deviations, p values in parentheses.
b Maximum cell value test, p values in parentheses.e American Journal of Human Genetics 85, 64–75, July 10, 2009 67
Figure 1. Genealogy of ADRB2 Inferred Haplotypes Reconstructed through a Median-Joining Network
Each node represents a different inferred haplotype, the size of the circle proportional to frequency. Nucleotide differences between
haplotypes are indicated on the branches of the network. Circles are color coded according to population (yellow: YRI, green: NSA,
blue: EU, red: EAS, pink: AUA). The chimpanzee sequence is also shown (black circle). Note that the relative position of mutations along
a branch is arbitrary. The amino acid status at positions 16 and 27 is shown for the four major inferred haplotypes.positions 16 and 27 is shown above each haplogroup and
indicates that chromosomes carrying Arg16/Gln27 alleles
are split among HB and HC1 in all population samples ex-
cept for EU (there are no EU chromosomes in haplogroup
C1); conversely, both Gly16/Gln27 and Gly16/Glu27
chromosomes cluster together to HA and HC2, respectively.
Therefore, we analyzed the location and possible func-
tional signiﬁcance of variants along the branches sepa-
rating HA-HB, HB-HC1, and HC1-HC2.
HA and HB are separated by ﬁve mutations (Figure 1). In
addition to codon16, oneof them(rs12654778) fallswithin
a noncoding region, upstream of the 50 UTR, that is highly
conserved among mammals. With respect to variants
separating HB and HC1, all of them are located upstream of
the transcription start site, suggesting that the two clades
have beenmaintained by transcription-regulatory variants.
Analysis of sequence conservation along this genomic
region indicated that variant 13 (rs17778257) is located
within an element highly conserved among placental
mammals. Further supporting their role as regulatory vari-
ants, both of these SNPs located within highly conserved
sequences have previously been identiﬁed as cis-acting
expression QTLs in a genome-wide analysis.5368 The American Journal of Human Genetics 85, 64–75, July 10, 200Drysdale and colleagues54 had previously analyzed
ADRB2 haplotype structure: their haplotypes 2 and 4, cor-
responding to HB and HC1, showed differential promoter
activity, in line with the vision whereby variants along
branch HB/HC1 affect gene expression levels. Finally, HC1
and HC2 differ with respect to codons 16 and 27.
There are different possible reasons underlying selection
signatures at human loci. Therefore, we calculated the ratio
of observed heterozygosity to expected gene diversity. In
order to obtain an estimate of this parameter in the human
genome, ratios were also calculated for 5 kb windows
deriving from NIEHS genes. Surprisingly, the observed
heterozygosity to expected gene diversity for ADRB2 in
EU and EAS falls below the ﬁfth percentile of values
obtained fromNIEHS genes (Table S3).We thereforewished
to verify whether any deviation from Hardy-Weinberg
equilibrium (HWE) could be observed. In EU, who lack
inferred haplotypes in clade HC1, typing of rs1042714
(Arg16Gly) and rs1042713 (Gln27Glu) allows unambig-
uous reconstruction of the six possible genotypes deriving
from the segregation of the three ADRB2 inferred haplo-
types. Analysis of the 60 unrelated CEPH individuals in
HapMap indicated a marginally signiﬁcant deviation from9
Table 4. Genotype Counts, Inferred Haplotype Frequencies, and HWE p Values in Four Populations
Genotype Counts Haplotype Frequencies
Pop. Count HAHA HBHB HCHC HAHB HAHC HBHC Sample Size HA HB HC HWE p Value
CEUd
All OBSa 5 7 19 11 5 13 60 0.22 0.32 0.46 0.0356
EXPb 2.82 6.02 13.07 8.23 12.13 17.73
Dutche
All OBSa 315 1376 1776 1257 1481 2986 9191 0.18 0.38 0.44 0.256
EXPb 308.5 1330.9 1749.1 1281.6 1469.3 3051.5
RFc 0.99 1 0.99 0.96 0.99 0.96
Females OBSa 175 759 996 700 845 1603 5078 0.19 0.38 0.44 0.094
EXPb 177.6 717.9 969.7 714.1 829.9 1668.8
RFc 0.93 1 0.97 0.93 0.96 0.91
Males OBSa 140 608 780 557 637 1383 4105 0.18 0.38 0.44 0.874
EXPb 133.0 605.3 780.3 567.5 644.3 1374.6
RFc 1 0.95 0.95 0.93 0.94 0.96
Frenchf
All OBSa 58 157 181 158 190 385 1129 0.205 0.380 0.415 0.053
EXPb 47.67 162.63 194.41 176.11 192.55 355.63
RFc 1 0.79 0.77 0.74 0.81 0.89
Females OBSa 30 85 89 63 98 197 562 0.20 0.38 0.42 0.009
EXPb 21.8 82.4 99.6 84.8 93.2 181.2
RFc 1 0.75 0.65 0.54 0.76 0.79
Males OBSa 28 72 92 95 92 188 567 0.21 0.38 0.41 0.421
EXPb 26.0 80.6 94.8 91.5 99.3 174.9
RFc 1 0.83 0.90 0.96 0.86 1
Italiang
All OBSa 35 109 78 132 135 165 654 0.26 0.39 0.35 0.110
EXPb 43.4 101.4 79.5 132.7 117.5 179.5
RFc 0.70 0.94 0.85 0.87 1 0.83
Females OBSa 13 53 40 63 69 72 310 0.25 0.39 0.36 0.0368
EXPb 20.1 46.8 39.4 61.4 56.3 85.9
RFc 0.53 0.92 0.83 0.84 1 0.68
Males OBSa 22 56 38 69 66 93 344 0.26 0.40 0.34 0.876
EXPb 23.3 54.6 40.1 71.3 61.1 93.6
RFc 0.88 0.95 0.88 0.90 1 0.92
a Observed count.
b Expected count.
c Relative fitness.
d CEPH samples extracted from the HapMap Project.
e Dutch samples derived from Sethi et al.55
f French samples derived from Dallongeville et al.56
g Italian samples derived from this study.HWEandan excess of homozygotes (Table 4). Therefore,we
searched the literature, looking for ADRB2 genotypes at
both polymorphisms in large European cohorts. In theThetwo available studies,55,56 we observed a marginally signiﬁ-
cant deviation inwomen in one study only, whichwe repli-
cated in our own genotyped Italian sample (Table 4).American Journal of Human Genetics 85, 64–75, July 10, 2009 69
Because deviations from HWE are not observed in all
cohorts and display marginally signiﬁcant p values (with
the exception of the French female sample), we cannot
reach deﬁnitive conclusions, although the possibility that
the results are due to genotyping artifacts or other unrecog-
nized biases (e.g., a deletion segregating in the populations)
is unlikely, given that (1) HWE deviation was observed in
women but not in men, (2) different studies used different
genotyping techniques, and (3) by analyzing 73 Italian
trios, we did not detected inconsistent segregation of
ADRB2 inferred haplotypes (not shown).
A Selective Sweep at ADRB3
As reported above, negative values of frequency-spectrum-
based statistics were obtained for ADRB3. This result can
be interpreted as evidence of either purifying selection or
selective sweep, given thatbothprocesses result in anexcess
of low-frequency variants. Fay andWu’sH is usually applied
to distinguish between the two possibilities.38 Negative H
values indicate an excess of high-frequency derived alleles,
a ﬁnding consistent with the action of directional but
not purifying selection. Given that selective sweeps are
expected to affect genomic regions surrounding the
selected variant(s), we calculated H (and performed all
successive analyses) over the whole resequenced region
(which extends ~3.8 kbdownstreamof the30UTR). A signif-
icantly negative H value was obtained for YRI and EU (H ¼
6.72, p ¼ 0.014 and H ¼ 7.33, p ¼ 0.045, respectively).
In order to obtain a further conﬁrmation, we applied
a composite-likelihood ratio test (CLR57), which evaluates
the local reduction of variation and skew of the frequency
spectrum. At ﬁrst, we evaluated statistical signiﬁcance of
likelihood ratio (LR) values in two ways: distinguishing
ancestral from derived alleles and then not distinguishing
allele states (Test 1 and Test 2, respectively). Results are
summarized in Table 5 and indicate that, after coalescent
simulations, data for Africans ﬁt signiﬁcantly better a hitch-
hiking event for both conditions; conversely, for Euro-
peans, only Test 1 gave signiﬁcant results. Given that
CLR is not robust to demographic history, we applied
a goodness of ﬁt (GOF) test;58 this method speciﬁcally tests
how well a selective sweep model ﬁts the data, as opposed
Table 5. Composite Likelihood Ratio Test for ADRB3
Test 1a Test 2b Test 3
c
Pop. LRd GOFe LRd GOFe LRd
YRI 12.74 (0.002) 453 (0.38) 12.45
(<0.0001)
3438 (0.060) 7.26
(0.60)
EU 9.34 (0.002) 550 (0.040) 3.25 (0.07) 1615 (0.044) n.a.f
a Distinguishing ancestral and derived allele.
b Nondistinguishing ancestral and derived allele.
c Distinguishing ancestral and derived allele only for inferred haplotypes
carrying the putative selected allele (W64).
d Likelihood ratio, p values in parentheses.
e Goodness-of-fit test, p values in parentheses.
f Not analyzed.70 The American Journal of Human Genetics 85, 64–75, July 10, 200to a generalized alternative model, by simulating gene-
alogies under directional selection. Thus, nonsigniﬁcant
p values represent a good ﬁt of the sweep model to the
data, whereas low p values fall within the range of effects
that can also be generated by demographic events such
as population bottlenecks or undetected population struc-
ture. For YRI, the GOF p values suggest that rejection of
neutrality by the CLR test is more likely due to a selective
sweep than to demographic history (Table 5). In contrast,
the GOF test fails to discard a relevant demographic effect
for Europeans.
As reported in the Introduction, the ancestral R64 allele
has been associated with obesity and insulin resistance in
some populations, and its frequency is relatively low in
Europeans, Asians, and Africans.29 As a consequence, the
W64 derived allele, the only high-frequency derived allele
in the ADRB3 coding sequence, might be a good candidate
to represent the selected variant. Therefore, we performed
an additional test for YRI under the assumption that an
incomplete sweep has been ongoing, with the W64 allele
being the selected site. To this aim, only inferred haplo-
types carrying the W64 allele were selected and LR value
was compared with those obtained by simulating data
under a complete sweep model59 (Test 3). Nonsigniﬁcant
p values (Table 5) make this evolutionary hypothesis very
appealing.
Haplotype analysis indicated that a total of 27 ADRB3
inferred haplotypes can be identiﬁed (Figure 2), but one
inferred haplotype carrying the W64 allele occurred 55
times and accounted for 45.8% and 71% of African and
European chromosomes, respectively. The Hudson haplo-
type test60 for the W64 variant indicated that signiﬁcantly
fewer (p ¼ 0.0046) inferred haplotypes than expected
under neutrality are observed in YRI. We then constructed
a median-joining network for ADRB3 inferred haplotypes
(Figure 3). Given the presence of a few recombination
events immediately downstream of the transcription end
site, the gene region extending from the most 50 rese-
quenced nucleotide to the 30 UTR end was used for this
analysis. As shown in Figure 3, all haplotypes carrying
the W64 allele (mutation 11 in the network) cluster
together or are few steps away from the major haplotype,
except for a divergent branch of African haplotypes.
These data are consistent with directional selection at
the ADRB3 locus in YRI. With respect to the European
sample, most tests failed to reject neutrality; yet, it should
be noted that only eight SNPs are segregating in this pop-
ulation, possibly resulting in insufﬁcient power to detect
deviations from the neutral expectations.
Discussion
In this work, wewished to analyze the evolutionary history
of ADRB genes in humans, with particular concern to selec-
tive patterns. Indeed, it has been proposed61,62 that popula-
tiongenetics approaches canbe regarded as a counterpart to9
classic association studies, in that by focusing on the effect
of susceptibility alleles on evolutionary ﬁtness, they allow
inference of functional relevance. Consistently, it has
Figure 3. Genealogy of ADRB3 Inferred Haplotypes Recon-
structed through a Median-Joining Network
Each node represents a different inferred haplotype, the size of the
circle proportional to frequency. Nucleotide differences between
haplotypes are indicated on the branches of the network. Circles
are color-coded according to population (gray: YRI, white: EU).
The chimpanzee sequence is also shown (black circle), and the
arrow indicates the W64 polymorphism.
Figure 2. Analysis of ADRB3 Inferred
Haplotypes
Polymorphic positions are color coded
according to their allelic state (white:
derived, red: ancestral). The position of
the W64R variant is shown, and inferred
haplotypes are ordered on the basis of the
allele at codon 64.
been shown63 that genes targeted by
selection acting on segregating vari-
ants are more likely to be associated
with human diseases.
Data reported herein indicated that
the genomic region covering the
promoter and coding sequences of
ADRB2 displays high nucleotide
diversity, an excess of intermediate-
frequency alleles, and a higher level
of within-species diversity in comparison to interspeciﬁc
divergence. All of these features strongly suggest the action
of balancing selection. In particular, analysis of inferred
haplotypes indicated that the three clades are likely to be
maintained by both coding and regulatory balanced SNPs,
being consistent with a model of multiallelic balancing
selection. As shown by the median-joining network
(Figure 1), three lineages are observed (as opposed to two
expected clades in the case of a biallelic model). This is in
line with values of the test statistics (Tajima’s D and Fu
and Li’s F* and D*), which are not strikingly positive; the
skew toward intermediate frequency variants tends to be
less marked in a multiallelic selection model than in the
case of biallelic selection. Estimation of TMRCAs for
ADRB2 inferred haplotype clades indicated that they are
not unusually deep. Thus, an alternative possibility is that
variants in the gene are going through a selective sweep;
indeed, both balancing and positive selection are initiated
by the spread in a population of a newly selected allele(s)
until either selection opposes (balanced situation) or
promotes (complete sweep) its ﬁxation.Populationgenetics
analyses such as the one reportedherein provide a snapshot
of a dynamic evolutionary process, making it difﬁcult to
precisely determine the underlying selective regime.
It is worth mentioning that the ADRB2 inferred haplo-
type structure might harbor implications for association
studies. Indeed, whereas in Europeans, all chromosomes
carrying alleles Arg16 andGln27display the samepromoter
structure (clade HB), in all other population samples,
inferred haplotypes harboring these coding variants are
split into two groups (HB and HC1) with different alleles in
the promoter region and, possibly, different transcriptional
activity.53,54 This observation might partially explain the
low consistency among association studies in different
population samples.
In analogy to the underlying selective regimes, the nature
of selective pressures acting on human genes is oftenThe American Journal of Human Genetics 85, 64–75, July 10, 2009 71
difﬁcult to identify. Our analyses of different European
cohorts suggests that ADRB2 inferred haplotypes deviate
from HWE in females but not in males. Deviations from
HWE in a sex-dependent manner have previously been
reported for variants in the BRCA2 gene (MIM 600185) in
humans.64 Still, in the case ofADRB2, deviations fromHWE
often displaymarginally signiﬁcant p values, and genotypes
with maximum and minimum relative ﬁtness are different
across the three Europeanpopulations (Table 4), an observa-
tion difﬁcult to reconcile with simple selection models.
Previous theoretical modeling has demonstrated that
different situations, including maternal (parental) selec-
tion65,66 and epistasis,67 can result in complex genotype
distributions and oscillations in genotype frequencies. In
theory, both effects might apply to ADRB2, although
maternal selection is supported by previous ﬁndings indi-
cating that both fetal18,22 and maternal19–21 genotype at
singleADRB2 SNPs predispose to preterm delivery and cere-
bral palsy. Unfortunately, none of these studies addressed
the role of sex in pregnancy outcome. A known example
of genetic variation inﬂuencing intrauterine viability
concerns the methylenetetrahydrofolate reductase gene
(MTHFR [MIM 607093]),68 and, in analogy to what we
observed for ADRB2, deviations from HWE in different
human populations have been observed, as an excess of
either homozygotes or heterozygotes in Italy and Finland,
respectively.69 Another instance involves the phospho-
glucomutase 1 (PGM1 [MIM 171900]) gene. The joint
maternal-neonatal distribution of PGM1 genotypes has
been shown to deviate from that expected under HWE,70
and the same authors reported that a signiﬁcant association
is observed between birth weight and mother-newborn
PGM1 genotype in infant females but not males.71
Additional studies will be required for verifying whether
selection for intrauterine viability (or viability in adult life)
does occur on ADRB2 haplotypes and determining
whether it is responsible for the selection signature that
we observed. Indeed, the central role played by ADRB2 in
many physiologic pathways suggests that it might have
been a target of diverse selective pressures.
Polymorphic variations in the gene have been associated
with three extremely frequent conditions: asthma, hyper-
tension, and obesity (or insulin resistance). Some recent
theories29,30 proposed these common diseases to be wide-
spread in human populations because susceptibility alleles
have been selected for during human evolution and have
more recently become unfavorable as a consequence of
changed environmental condition and lifestyle. In partic-
ular, it has been suggested29 that alleles responsible for
type 2 diabetes might have evolved as ‘‘thrifty’’ variants
in ancient populations; similarly, variants predisposing to
asthma and atopy possibly conferred increased resistance
to parasites in endemic areas. Finally, susceptibility alleles
for hypertensionwere proposed to have conferred selective
advantage to populations adapted to hot and humid
climates in order tomaximize sodium retention or vascular
reactivity.29,30 These evolutionary-framework hypotheses72 The American Journal of Human Genetics 85, 64–75, July 10, 200might well ﬁt ADRB2 coding variants. Indeed, the ancestral
Glu27 allele has been associated with obesity in a number
of studies and the three b-adrenergic receptors are known
to play pivotal roles in regulating metabolic rate and ther-
mogenesis.72 Also, the ancestral Gly16 variant has been
associated with both asthma and resistance to A. lumbri-
coides infection,23 and a latitudinal cline has been identi-
ﬁed for Gly16 and Glu27, the two ancestral variants being
possibly adapted to hot climates.73 The ancestral amino
acid state at codons 16 and 27 might therefore have
conferred some selective advantage with respect to energy
storage, ascariasis, and vascular reactivity. Yet, some recent
evidence suggests that additional selective pressures might
have been acting on ADBR2 variants. Indeed, signaling via
ADRB2 and heterotrimeric guanine nucleotide-binding
proteins has been shown to regulate the entry74,75 and
intracellular maturation75 of Plasmodium falciparum in
erythrocytes. Malaria (MIM 611162) is thought to have
exerted a strong selective pressure on humans, resulting
in the selection of hundreds of genetic variants conferring
some disease protection; it is therefore conceivable that
Plasmodium infection has exerted some selective pressure
on ADRB2 polymorphisms, as well.
In analogy to ADRB2 the ancestral susceptibility model
might apply to ADRB3; other authors29 suggested that the
ADRB3 Arg64 allele might represent a thrifty variant.
Although the contribution of ADRB3 genotypes to the
etiology of obesity and type 2 diabetes is still controversial,
a meta-analysis76 indicated that the Arg64 variant plays a
modest but signiﬁcant role in the susceptibility to non-
insulin-dependentdiabetesmellitus.Moreover, a consistent
association with younger age at onset of diabetes has been
reported in several analyses.76–79 Similarly, a study80 based
on paired sibling analysis indicated a signiﬁcant association
between the ADRB3 Arg64 allele and obesity. In line with
these ﬁndings, homozygotes for the Arg64 allele display
lower metabolic resting rates as compared to those of
subjects carrying at least one Trp64 variant,81 and the
Arg64 allele might associate with mild gestational diabetes
and increased weight gain in pregnancy.82 Despite its
appeal, the thrifty-genotypehypothesishas received limited
experimental support, and a limited number of studies83–85
have attempted to apply population genetics approaches to
detect selection signatures at thrifty variants. Here, we have
shown that the the derived Trp64 variant, which possibly
represents a nonthrifty allele, has raised in frequency in
human populations as a result of directional selection.
The speciﬁc selective pressure underlying this event
remains to be identiﬁed, although changes in diet, which
are thought to have occurred during recent human history,
might have resulted in widespread selection of genes
involved in energy metabolism.86
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